Skip to content

The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects

The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects: A Pilot Study

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01719419
Enrollment
0
Registered
2012-11-01
Start date
2012-03-31
Completion date
2012-09-30
Last updated
2015-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight

Brief summary

The purpose of this study is to determine if the drug orlistat (Alli, Xenical) decreases the taste for fat in humans.

Detailed description

One screening visit and Testing Visits 1 and 2: Approximately 1-2 hours (Fasting - You will have nothing to eat or drink (except water or medications) after midnight before the test visit.) If you qualify for the study, you will return to Pennington Biomedical Research Center for the test visit * You will be given a questionnaire to screen for allergies or cold symptoms. * Women will answer a questionnaire based on their menstrual cycle. * Before eating, you will be given instructions on how to use the study medication. You will swish about 2 teaspoons of a solution in your mouth for 30 seconds and then spit it out (like mouthwash). * Just before eating, you will be given another brief questionnaire judging your appetite. * You will be given the test meal. You will be allowed to eat as much or as little as you like during a 20-minute eating period. * 30 minutes after starting your meal you will be given the brief questionnaire again to judge your appetite. * You will return in 1 month to complete test visit 2.

Interventions

DRUGPlacebo

Measured fatty food intake and appetite at a single lunch meal after the administration of modified sham feeding technique with placebo.

DRUGOrlistat

Measured fatty food intake and appetite at a single lunch meal after the administration of modified sham feeding technique with orlistat.

Sponsors

Pennington Biomedical Research Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Are a healthy male or female, * Are between 18 to 70 years of age, * Have a body mass index between 25-35 kg/m2

Exclusion criteria

* Are a female who is pregnant or nursing, * Are a restrained eater (determined using a questionnaire), * Have any current illnesses such as an infection, * Have any serious medical problems including kidney, liver, heart or lung disease, * Use medications known to increase appetite, * Are taking any medication that has not been on the same dose for at least 30 days, * Dislike the test food.

Design outcomes

Primary

MeasureTime frameDescription
Does orlistat decreases the taste for fatty food intake1 month* Before eating, you will be given instructions on how to use the study medication. You will swish about 2 teaspoons of a solution in your mouth for 30 seconds and then spit it out (like mouthwash). * Just before eating, you will be given another brief questionnaire judging your appetite. * You will be given the test meal. You will be allowed to eat as much or as little as you like during a 20-minute eating period. * 30 minutes after starting your meal you will be given the brief questionnaire again to judge your appetite. * You will return in 1 month to complete test visit 2.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026